|
JP2012025776A
|
|
Function restoration agent for retina neurocyte
|
|
WO2010061902A1
|
|
Screening method, composition containing substance selected by the screening method, and binding substance
|
|
JP2010090055A
|
|
Medicine for administration to pregnant woman
|
|
WO2007138961A1
|
|
Prophylactic or therapeutic agent for disorder induced by macrophage migration inhibitory factor
|
|
US2008104722A1
|
|
Disease model animals of metabolic syndrome and a method of screening preventive and therapeutic agents for metabolic syndrome using the same
|
|
JP2007302633A
|
|
Agent for prevention or treatment of damage caused by injurious ingredient contained in smoke generated in burning of fiber
|
|
JP2007269671A
|
|
Preventing or treating agent of allergic dermatitis
|
|
WO2006090849A1
|
|
Preventive or remedy for inflammatory ocular surface diseases
|
|
EP1736168A1
|
|
Protease inhibitor and preventives or remedies for diseases
|
|
JP2005060408A
|
|
Prophylactic or therapeutic agent for chronic obstructive pulmonary disease
|
|
JP2006151861A
|
|
Preventing and treating agent of organ disorder caused by smoking
|
|
JP2006109754A
|
|
Food inducing expression of thioredoxin
|
|
JP2005225853A
|
|
Agent for prevention and treatment of allergic disease or respiratory disease
|
|
US2006110378A1
|
|
Agent for treatment of inflammatory bowel disease
|
|
JP2004067542A
|
|
Agent for treating acute hepatitis and chronic hepatic fibrogenesis
|
|
JP2004010574A
|
|
Nerve regeneration factor
|
